Company intelligence / Profile preview

Crux Biolabs

Bayswater/Melbourne, Victoria, Australiacruxbiolabs.com ↗

Ownership: Private
Development stage: Other

Overview

Crux Biolabs offers accredited bioanalytical and central laboratory services supporting clinical and pre-clinical trials with expertise in immunology of vaccines, infectious diseases, and oncology. Services include large molecule PK/ADA testing, biomarker detection, cell-based assays and more in an ISO/IEC 17025 NATA-accredited lab.

Therapeutic areas: OncologyImmunologyInfectious Diseases
Modalities: Biologic (focus on large molecule pharmacokinetics, ELISA, multiplex immunoassays)Small molecule (LC-MS/MS analysis for PK studies)Cell-based assays (flow cytometry, cell characterization)Protein analysis (ELISA, ECL, bead array assays)Nucleic acid extraction
Industry: Contract Research Organization

Beyond the preview

Go deeper on Crux Biolabs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Crux Biolabs.

Explore the full profile